This report from Life Science Intelligence provides the latest market data for the Global Inferior Vena Cava Filters Market. Information covered by this report includes:
· unit volumes & pricing forecast from 2019-2024
· analyses of the leading companies, and
· global market share analysis.
The global market for inferior vena cava filters is expected to reach an estimated $293.8 million in 2020 and is projected to decrease at a CAGR (2020-2024) of (-1.0%). Products covered by this report include inferior vena cava filters.
This report covers the impact of COVID-19 on the inferior vena cava filters market, including a recent forecast from 2020 to 2024. COVID-19 has also impacted leading competitors, such as BD, Boston Scientific, Cook Medical, Cardinal Health, and others. The report provides insights into trends, drivers, and limiters of the inferior vena cava filters market, as well as highlights potential opportunities.
The inferior vena cava filter market is expected to decline by a substantial margin due to the COVID-19 pandemic. Prior to the pandemic, inferior vena cava procedures have been on the decline due to adverse events associated with the use of these devices in the past.
The market for inferior vena cava filters is heavily saturated with several key competitors. However, new players such as Bio2 Medical and Novate Medical have developed tethered temporary filters and convertible filters, respectively, that are expected to mitigate concerns and drive confidence in the utilization of these types of devices.
Inferior vena cava filters (IVC) are used as a measure to prevent pulmonary embolism (PE) in patients with venous thromboembolism and contraindication to the use of blood thinners. Other indications for an IVC include Deep Vein Thrombosis (DVT), trauma, and surgical patients.